Jimenez Garcia, L. I., Asquel Caiza, S. D., Rogel Macas, E. I., Santodomingo Galindo, A. F., Dede Badillo, G. E., & Nolasco Toledo, A. (2025). Tumor-infiltrating lymphocyte (TIL) therapy for immunotherapy-refractory advanced melanoma: a systematic review of response and survival rates. Ibero-American Journal of Health Science Research, 5(2), 392–399. https://doi.org/10.56183/iberojhr.v5i2.845